- Companies focusing on obtaining approvals for pediatric drugs from the regulatory authorities in order to expand their product portfolio and strengthen their presence is expected to fuel the growth of the pediatric palliative care drugs market over the forecast period. For instance, in October 2019, Novartis International AG received approval from the U.S. Food and Drug Administration (FDA) for Entresto, indicated for the treatment of symptomatic heart failure (HF) with systemic left ventricular systolic dysfunction in pediatric patients aged 1 year and older.
- The demand for pediatric palliative care drugs is projected to increase as the incidence of congenital heart diseases increases. According to the Australian Institute of Health and Welfare (AIHW). Around 5,000 hospitalizations with 1 in every 3 infants under the age of 1 year were reported in Australia between 2016 and 2017.
Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/4251
Covid-19 Impact:
The COVID-19 pandemic has severely hampered the availability of palliative care drugs inpatient and outpatient facilities, as well as home visits. During the pandemic, palliative care wards introduced stringent admission requirements, including:
- COVID-19 infection requires stringent screening protocols for children and their families, including COVID-19 contact history examinations, chest computed tomographic scans, and nucleic acid tests.
- After two weeks of isolation, children with qualified screening results may be admitted to the ward.
- Non-local children were subjected to strict admission requirements than those from the surrounding areas. During the COVID-19 pandemic, infection prevention and control (IPC) interventions delayed transfer to the palliative care ward, and some children were unable to be admitted at all.
- In addition, in order to avoid the spread of COVID-19, the paediatric palliative care team changed their work habits, allowing only a few key members, such as nurses and physicians, to enter the palliative care wards.
Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/4251
Key Takeaways:
- Companies focusing on obtaining approvals for pediatric drugs from the regulatory authorities, in order to expand their product portfolio and strengthen their presence in the market is expected to boost the growth of the pediatric palliative care drugs market.
- Among drug class, the analgesics segment held a dominant position in the pediatric palliative care drugs market in 2019, owing to the high prevalence of heart disease in pediatric patients. According to the 2016 National Survey of Children’s Health (NSCH), the prevalence of heart conditions among children in the U.S. aged 0–17 years was estimated to be approximately 1.3%.
- The global pediatric palliative care drugs market is expected to exhibit a CAGR of 5.1% over the forecast period, owing to the increasing prevalence of congenital heart disease. According to the Australian Institute of Health and Welfare (AIHW), around 9 in every 1,000 babies born are affected with congenital heart disease.
- Major players involved in the global pediatric palliative care drugs market include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu’an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co., Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
“Limited Period Offer”
Buy This Complete Business Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/4251
Main points in Pediatric Palliative Care Drugs Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Pediatric Palliative Care Drugs Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Pediatric Palliative Care Drugs Industry Impact
Chapter 2 Pediatric Palliative Care Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Pediatric Palliative Care Drugs (Volume and Value) by Type
2.3 Pediatric Palliative Care Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Pediatric Palliative Care Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Pediatric Palliative Care Drugs Market Analysis
Chapter 6 East Asia Pediatric Palliative Care Drugs Market Analysis
Chapter 7 Europe Pediatric Palliative Care Drugs Market Analysis
Chapter 8 South Asia Pediatric Palliative Care Drugs Market Analysis
Chapter 9 Southeast Asia Pediatric Palliative Care Drugs Market Analysis
Chapter 10 Middle East Pediatric Palliative Care Drugs Market Analysis
Chapter 11 Africa Pediatric Palliative Care Drugs Market Analysis
Chapter 12 Oceania Pediatric Palliative Care Drugs Market Analysis
Chapter 13 South America Pediatric Palliative Care Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Pediatric Palliative Care Drugs Business
Chapter 15 Pediatric Palliative Care Drugs Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
continued………….
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/4251
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837